Canagliflozin use in patients with renal impairment—Utility of quantitative clinical pharmacology analyses in dose optimization

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|55|6|647-656

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.6, 2015-06, pp. : 647-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 3, 2018-03 ,pp. : 378-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development, implementation and outcome analysis of semi‐automated alerts for metformin dose adjustment in hospitalized patients with renal impairment

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 25, Iss. 10, 2016-10 ,pp. : 1204-1209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: high oral dose of taurine for portal hypertension in cirrhotic patients—some clinical pharmacology considerations

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 861-862

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain

By Otis James   Rothman Margaret  

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1493-1501

Informa Healthcare

Access to resources Recommend Favorite

Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron‐sparing surgery

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 590-595

John Wiley & Sons Inc

Access to resources Recommend Favorite